Infliximab for refractory ulcerative proctitis
نویسندگان
چکیده
منابع مشابه
Infliximab for refractory ulcerative proctitis.
BACKGROUND Efficacy of infliximab in treating ulcerative proctitis remains unknown. AIM To evaluate the clinical, biological and endoscopic efficacy of infliximab therapy in refractory proctitis. METHODS The charts of 420 patients treated with infliximab for ulcerative colitis were reviewed. Thirteen patients were treated with infliximab for refractory ulcerative proctitis in six referral c...
متن کاملRefractory Ulcerative Proctitis—A Brief Review
Ulcerative proctitis (UP) is a common condition in adult patients and can be very difficult to treat. This review considers critically the definition of this entity, its epidemiology and course, and the modes of therapy currently available. Therapies currently in development are considered as well.
متن کاملEconomic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis
The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to sev...
متن کاملUlcerative Proctitis
Ulcerative colitis (UC) is a chronic inflammatory disease of digestive tract of unknown cause. This disease is characterized by a chronic course with alternating periods of activity and clinical remission. The incidence of UC in America has a range extending from 2.2 to 14.3 per 100,000 population per year [1]. The continuous involvement from the rectum to proximal presents an extension that is...
متن کاملLong-term outcome after infliximab for refractory ulcerative colitis.
BACKGROUND AND AIMS Infliximab (IFX) has been shown efficacious for moderate-to-severe ulcerative colitis (UC), but data on long-term efficacy are lacking. We investigated long-term outcome including colectomy rates in outpatients treated with IFX for refractory UC in a single referral centre, and evaluated if predictors could be identified. METHODS The first 121 outpatients (median age 38.0 ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alimentary Pharmacology & Therapeutics
سال: 2010
ISSN: 0269-2813,1365-2036
DOI: 10.1111/j.1365-2036.2010.04293.x